LevFin vs Rx for Special Sits and Private Credit Exits

All, haven't been able to find many data points and am wondering if anybody can share some color on exits from a levfin group vs rx group into distressed / special sits and DL roles. Am assuming here this is a levfin group that sits within IBD and has a banking orientation with strong technical development versus the purely capital markets focused levfin groups. 

Would consider a top exit into a shop that invests across the cap stack - would I be better off coming from Rx or levfin group to achieve this? Is there an inflection point where a top levfin group is better than a lower tier rx group? Does levfin have a better shot at DL and Rx have a better shot at Distressed or some similar propensity? Appreciate any thoughts or data points you can share.

4 Comments
 

I think people will generally give more credit to an RX background. From RX you can easily recruit into direct lending, but it would not be as easy to go from LevFin to distressed (not impossible by any means, though). I'm not saying that perception necessarily right in every case, but all else being equal rx situations tend to be more complex/unique/faster moving than LevFin.

For firms of similar caliber, I'd take the RX seat any day of the week. Get's a bit tougher when you're talking about a top tier LevFin shop vs. mediocre RX. You'd really have to evaluate it on a case by case basis. I'd take JPM LevFin over Rothschild RX, for example. Would recommend shooting for both and seeing what you can land. There should be a lot of overlap in prep at the summer analyst/analyst level anyways. 

Array
 

Asperiores nam ipsam tenetur doloremque consequatur doloremque. Soluta in aliquam nisi reiciendis. Nihil numquam ipsum facere optio est. Dolorem modi soluta nihil officiis qui et nam.

Necessitatibus alias facere dolorem nemo perspiciatis facilis suscipit. Delectus debitis eaque perspiciatis cum non eaque incidunt. Nemo vitae quia fugit enim. Magnam cumque consequatur et inventore ab ex.

Harum qui laboriosam sunt dolores. At molestiae et unde. Saepe debitis earum autem illum ipsam est tempora.

Unde sed explicabo commodi. Omnis magni id et vero maiores quo. Et distinctio odio et numquam.

Career Advancement Opportunities

September 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

September 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.3%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Warburg Pincus 98.1%

Professional Growth Opportunities

September 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

September 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (100) $364
  • 3rd+ Year Associate (106) $280
  • 2nd Year Associate (235) $272
  • 1st Year Associate (414) $231
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (273) $126
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
DrApeman's picture
DrApeman
98.9
9
CompBanker's picture
CompBanker
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”